Tag Archives: Research

arcview market

NEW REPORT: Worldwide Spending on Legal Cannabis will Reach $57 Billion by 2027

NEW REPORT: Worldwide Spending on Legal Cannabis will Reach $57 Billion by 2027

OAKLAND, Calif., Feb. 26, 2018 /Weed Wire/ – Worldwide consumer spending on legal cannabis is projected to reach $57 billion by 2027, according to the “The Road Map to a $57 Billion Worldwide Market” report released today by Arcview Market Research, in partnership with BDS Analytics.

Study Finds MMJ Laws Do Not Increase Adolescent Cannabis Use

Study Finds MMJ Laws Do Not Increase Adolescent Cannabis Use

Although a majority of Americans support medical cannabis, a small segment of the population still opposes its legalization for fear that it will lead to an increase in adolescent cannabis use; however, according to a new study published in the journal Addiction, that fear may be unfounded.

Doubts Raised Over Marijuana’s Medical Benefits

A new medical marijuana guideline developed by Edmonton researchers warns family doctors that the risks may outweigh the benefits for the vast majority of patients. The guideline, published Thursday in the Canadian Family Physician journal, suggests the benefits of medical cannabis may be overstated, and research on its medicinal properties is sorely lacking.

Study: Medical Cannabis Treatment Significantly Reduces Chronic Pain in Elderly

Study: Medical Cannabis Treatment Significantly Reduces Chronic Pain in Elderly

Baby boomers have become a growing market segment in the legal cannabis industry as the acceptance of medical cannabis treatment continues to spread across the world, and now it appears that medical cannabis treatment may offer senior citizens a safer alternative to opioids in the treatment of chronic pain.

Next Frontier Biosciences Scientific Advisory Board Colin Osborne

Next Frontier Biosciences Assembles Distinguished Research and Development Team

DENVER, Feb. 13, 2018 /Weed Wire/ – Colorado-based biotech company Next Frontier Biosciences today announced the assembly of its Research and Development Team, enhancing the company’s lineup of accomplished biotechnology executives and research scientists.

Study: Medical Cannabis May Not Be Panacea to Prevent Opioid-Related Deaths

It has often been touted by medical cannabis advocates that states with medical cannabis laws see a statistical reduction in opioid-related deaths, and there is some evidence to support this claim; however, a recent study conducted by the RAND Corporation and the University of California, Irvine, calls into question this assumption and paints a more complex picture.

Legal Weed: Politicians and Police Cashing in on New Industry

Legal Weed: Politicians and Police Cashing in on New Industry

Who gets to profit from Canada’s booming weed industry? Researchers at The Weekly found that nearly 40 former politicians and police officers are involved in medicinal marijuana companies, set to make retail sales as soon as it becomes legal.

Study: Cannabis Use May Reduce Risk of Alcohol-Related Liver Disease

Study: Cannabis Use May Reduce Risk of Alcohol-Related Liver Disease

Can cannabis protect individuals from alcohol-related liver damage? Maybe. According to a study published in the journal Liver International, heavy alcohol users that use cannabis on a daily basis have reduced incidence of liver disease than those that do not.

Canadian Cannabis Research Banks $1.4M in Funding From Government

Canadian Cannabis Research Banks $1.4M in Funding From Government

With the Great White North preparing to become the first G7 nation to launch recreational legalization, the federal government wants to inform its journey into uncharted territory by providing $1.4 million in funding to Canadian cannabis research projects.

Physical Security

Government of Canada Invests in New Cannabis Research

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – The impact of non-medical cannabis use in Canada has been the subject of much speculation and debate. There are still many uncertainties related to the health, social, and economic implications of cannabis legalization and regulation. A solid evidence base is needed for the ongoing development of the most effective policies, practices, and programs relating to the use of cannabis and its derivatives.

VA Says It Won't Study Medical Marijuana's Effect on Veterans

VA Says It Won’t Study Medical Marijuana’s Effect on Veterans

The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.

arcview market

NEW REPORT: Legal Marijuana Industry to Generate $40 billion in Economic Impact by 2021

OAKLAND, Calif., Jan. 2, 2017 /Weed Wire/ — The total economic output from legal cannabis will grow 150% from $16 billion in 2017 to $40 billion by 2021, according to the “US Legal Cannabis: Driving $40 Billion Economic Output” report released today by Arcview Market Research, in partnership with BDS Analytics.

Pot-Smoking on the Rise Among U.S. Pregnant Women

More pregnant women seem to be using pot — sometimes to ease the nausea of morning sickness or heightened anxiety — and a new study suggests that this slight rise in marijuana use is most pronounced among those younger in age.

GrowPros

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC

OTTAWA, Ontario, Dec. 13, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that the company has signed an exclusive research and development (R&D) agreement with Constance Therapeutics.

MMJ Took a Bite Out of Alcohol Sales. Recreational Pot Could Take More.

Alcohol sales fell by 15 percent following the introduction of medical marijuana laws in a number of states, according to a new working paper by researchers at the University of Connecticut and Georgia State University.

Kaiser Permanente Researchers Explore Patients’ Marijuana Use

SEATTLE, Nov. 27, 2017 /Weed Wire/ — About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year, according to a study conducted by Kaiser Permanente researchers since Washington state legalized nonmedical cannabis use in 2014.

Fox Business Network Capital Infusion

Agritek Holdings, Inc. Announces Expansion Plans For Additional 900 Acres In Pueblo, Colorado For CBD Research Cultivation Farm And New Infused Products Agreement

LOS ANGELES, Nov. 14, 2017 /Weed Wire/ — Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor for the cannabis sector and consultant for multiple cannabis brands today announced that the Company has agreed and entered into negotiations to purchase the surrounding nine-hundred (900) acres of its’ existing 80 acre Hemp planned research site in Pueblo, Colorado.

Israel Wants to Start Exporting Its Cannabis Around the World

When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked. Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital.

SAQ

Tilray Exports Medical Cannabis Genetics to the European Union

NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.

Organization in Ohio Is the New Holder of a DEA Marijuana Research License

Organization in Ohio Is the New Holder of a DEA Marijuana Research License

While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.

Lawmakers: Feds Should Research Medical Marijuana for Military Vets

Lawmakers: Feds Should Research Medical Marijuana for Military Vets

A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.

GOP Congressman Wants Trump to Help Legalize Medical Marijuana

GOP Congressman Wants Trump to Help Legalize Medical Marijuana

Rep. Matt Gaetz has been in Congress for less than a year, but the Florida Congressman has already become one of the House’s foremost leaders working to reform federal marijuana policies. Just one problem: GOP leadership doesn’t seem especially interested in giving the issue a fair shake.

Sen. Orrin Hatch Makes the Case for Medicinal Marijuana

Sen. Orrin Hatch Makes the Case for Medicinal Marijuana

In a Senate Judiciary Committee hearing Wednesday morning, Senator Orrin Hatch made the case for medical marijuana. During the hearing Hatch questioned U.S. Attorney General Jeff Sessions about a path forward for marijuana research.

3 Ways to Avoid Marijuana Stock Investment Scams

3 Ways to Avoid Marijuana Stock Investment Scams

Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.

46% of Canadians Would Try Cannabis Edibles If Available in the Legal Market

Study: Nearly 46% of Canadians Would Buy Cannabis Edibles If Available Legally

While Canada is planning to delay the roll out of recreational cannabis edibles for regulatory reasons, it may give stakeholders the added benefit of having extra time to master their formulations for what may become a booming market segment.

Green Market Report gmr

Green Market Report Partners with Consumer Research Around Cannabis to Release ‘Cannabis Freakonomics’ Series

NEW YORK, Sept. 27, 2017 /Weed Wire/ — The Green Market Report (GMR) has partnered with Consumer Research Around Cannabis to release a series of research market snapshots called ‘Cannabis Freakonomics’ highlighting interesting findings on the spending habits and profiles of cannabis consumers.

Report: California Cannabis Taxes to Keep Black Market Cannabis Alive

Report: California Cannabis Taxes to Keep Black Market Cannabis Alive

As the Golden State readies for the rollout of recreational cannabis on Jan. 1, 2018, some are preparing for a windfall of revenue from California cannabis taxes and others are preparing to continue competing with the black market.

Tennessee Medical Cannabis Task Force Tackles First Official Meeting

Tennessee Medical Cannabis Task Force Tackles First Official Meeting

On Sept. 21, 2017, the Tennessee medical cannabis task force, created by Lt. Gov. Randy McNally and State House Speaker Beth Harwell, met for the first time to discuss legalization.

Oregon Cannabis Commission

OHA Concludes Review of Youth Marijuana Use Prevention Pilot Campaign

PORTLAND, Ore., Sept. 20, 2017 /Weed Wire/ — An Oregon Health Authority (OHA) education campaign aimed at youth and young adults raised awareness among its target audience of the risks associated with marijuana use, an independent evaluation has found.

American Pain Society Supports Passage of Marijuana Effective Studies Act

CHICAGO, Sept.18, 2017 /Weed Wire/ – A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.

Cory Gardner

Gardner Backs Effort to Advance Medical Marijuana Research

WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment.

Gardner Backs Effort to Advance Medical Marijuana Research

Gardner Backs Effort to Advance Medical Marijuana Research

WASHINGTON, Sept. 14, 2017 /Weed Wire/ — Senator Cory Gardner (R-CO) introduced the Marijuana Effective Drug Study (MEDS) Act of 2017 to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. The legislation’s lead sponsor was Senator Orrin Hatch (R-UT).

This Is What Orrin Hatch Told the Senate About Medical Cannabis Research

This Is What Orrin Hatch Told the Senate About Medical Cannabis Research

On Sept. 13, 2017, U.S. Sen. Orrin Hatch, R-Utah, introduced legislation to cut the bureaucratic red tape thwarting medical cannabis research so health care professionals can harness the medicinal properties of the plant to reduce the suffering of patients in need.


Page 1 of 812345Last »
Top